Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EMU038861

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Ppif

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GTCAAAGAGGGCATGGATGTTGTGAAGAAAATAGAATCTTTCGGCTCAAAAAGTGGGAAGACGTCTAAGAAGATTGTCATCACAGACTGTGGCCAGTTGAGCTAACTCACAGCCAAGGTGCTAGGACAGCAGCAGGCATCCATGTCTTGATTCACCCAGGTTCTCCAAAGAACAGTTTGCACCCACTTCTATTGAGTCTGAGGAAGGCCACTCAGGCATGGTCCTCCCAGACCAGGCTGCTCTCCACTGTCCATCCTGCCTCAGATCCCGTTTCTGGGCATCAGTATGGCCATCGGGCCATGTACCCTCAGCCGATGTCCCCGTGATTGCCATGTGCGTGTGCCTTGGACATTGGCAATGCTGACCAGTTAGTCAGGGAAGGCTCCTGACTCTTTTCCTTGATCAGTGGGGATAGCAGTTGCTATTTAATGTTGTCTTCCTCCTTGCAATAATTTAACATAGAATTCAAGATCTCATCGAAACAAAGCTGTGACACTCATGGCACT

Ensembl | mouse accession no.

ENSMUSG00000021868

NCBI accession no.

NM_134084

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... PPIF(105675) , Ppif(105675)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Li-sen Qin et al.
Journal of experimental & clinical cancer research : CR, 34, 57-57 (2015-05-31)
The primary glioblastoma multiforme (GBM) is the most malignant form of astrocytic tumor with an average survival of approximately 12-14 months. The search for novel and more efficient chemo-agents against this disease is urgent. Salinomycin induces broad anti-cancer effects; however

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service